ProPhase Labs, Inc. (PRPH) - Latest Market Data

Track the most recent price, market cap, volume, and performance data for ProPhase Labs, Inc. (PRPH).

Download PennyGems on Google Play Download PennyGems on the App Store

Equity Overview

Price & Market Data

Price: $0.353

Daily Change: $0.00 / 0.00%

Range: $0 - $0

Market Cap: $14,791,662

Volume: 0

Performance Metrics

1 Week: 22.68%

1 Month: -17.73%

3 Months: -30.89%

6 Months: -85.28%

1 Year: -93.29%

YTD: -53.35%

Company Details

Employees: 96

Sector: Health technology

Industry: Pharmaceuticals: other

Country: United States

Details

ProPhase Labs, Inc. develops and commercializes novel drugs, dietary supplements, and compounds in the United States. It operates through two segments: Diagnostic Services and Consumer Products. The company provides a range of TK supplements, including Legendz XL for male sexual health; and Triple Edge XL, an energy and stamina booster. It offers contract manufacturing services, such as product development, pre-commercialization, production, warehousing, and distribution; COVID-19 diagnostic information services to a range of customers, including health plans, third party payers, and government organizations; and respiratory pathogen panel molecular and DNA testing services, as well as personal genomics products and services. In addition, the company involved in the research, development, manufacture, distribution, marketing, and sale of over the counter (OTC) consumer healthcare products and dietary supplements; and retail operations. The company was formerly known as The Quigley Corporation. ProPhase Labs, Inc. was founded in 1989 and is headquartered in Garden City, New York.

Selected stocks

Evolution Petroleum Corporation (EPM)

Natural Health Trends Corp. (NHTC)

Aspen Aerogels, Inc. (ASPN)